MYSE:NASDAQMyseum, Inc. Analysis
Data as of 2026-07-14 - not real-time
$2.78
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Myseum.AI, Inc. (MYSE) is trading at $2.78, comfortably above its 20‑day ($2.42), 50‑day ($2.02) and 200‑day ($2.11) simple moving averages, suggesting short‑term momentum. However, the 14‑day RSI sits at 68, edging into overbought territory, and volume has been trending lower, indicating waning buying pressure. The MACD line (+0.149) is just above its signal (+0.140) with a tiny positive histogram, offering a faint bullish signal but one that could be easily reversed given the stock’s 30‑day volatility of roughly 97% and a beta of 2.13, marking it as highly sensitive to market swings. Fundamentally, the company is in distress: revenue of $540 M is shrinking (-12% YoY), operating and net margins are deeply negative, cash flow is out of the red, and the debt‑to‑equity ratio exceeds 5, while valuation multiples are extreme (price‑to‑sales > 26,000×). The balance sheet is thin, with a market cap of only $14.4 M and a price‑to‑book of 3.1, underscoring the disconnect between market price and underlying performance. On the catalyst side, recent announcements of privacy‑first AI agents and a partnership with Scanon.ai to embed AI‑driven computer‑vision into the Picture Party platform could fuel speculative upside if the technology gains traction, but these initiatives remain early‑stage and unproven. Overall, the stock sits at a technical sweet spot but is weighed down by severe financial weakness and extreme volatility, making it a high‑risk speculative play.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price marginally above key moving averages but RSI near overbought
- Decreasing volume and extreme short‑term volatility
- Lack of earnings and negative cash flow
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Potential upside from privacy‑first AI agent development
- Strategic partnership with Scanon.ai expanding product capabilities
- Technical bias remains bullish despite fundamentals
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Sustained operating losses and high debt‑to‑equity ratio
- Extreme valuation multiples unsupported by revenue growth
- High beta and volatility make the stock vulnerable to market downturns
Key Metrics & Analysis
Financial Health
Revenue Growth-12.00%
ROE-115.18%
ROA-53.35%
Debt/Equity5.36
P/B Ratio3.1
Op. Cash Flow$-4327720
Free Cash Flow$-2767461
Industry P/E34.2
Technical Analysis
TrendNeutral
RSI68.0
Support$1.82
Resistance$2.80
MA 20$2.42
MA 50$2.02
MA 200$2.11
MACDBullish
VolumeDecreasing
Fear & Greed Index92.09
Valuation
GradeOvervalued
TypeGrowth
Risk Assessment
Beta2.13
Volatility97.25%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.